Cargando…
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
SARS-CoV-2 has caused over 2 million deaths in little over a year. Vaccines are being deployed at scale, aiming to generate responses against the virus spike. The scale of the pandemic and error-prone virus replication is leading to the appearance of mutant viruses and potentially escape from antibo...
Ejemplares similares
-
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
por: Zhou, Daming, et al.
Publicado: (2021) -
Antibody evasion by the P.1 strain of SARS-CoV-2
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2021) -
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022) -
Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
por: Dijokaite-Guraliuc, Aiste, et al.
Publicado: (2022) -
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
por: Liu, Chang, et al.
Publicado: (2022)